Califf is Bullish on Newly Authorized Bivalent COVID-19 Boosters Ahead of Data

By PacConAdmin | August 31, 2022

In the midst of a pandemic, if you wait for all the data to come in, “you’ve missed the boat,” said FDA Commissioner Robert Califf yesterday regarding the agency authorizing both Pfizer/BioNTech’s and Moderna’s bivalent COVID-19 boosters before any clinical trials on them are complete.
Source: Drug Industry Daily

Posted in Drug Industry Daily